SE8800541A - - Google Patents
Info
- Publication number
- SE8800541A SE8800541A SE8800541A SE8800541A SE8800541A SE 8800541 A SE8800541 A SE 8800541A SE 8800541 A SE8800541 A SE 8800541A SE 8800541 A SE8800541 A SE 8800541A SE 8800541 A SE8800541 A SE 8800541A
- Authority
- SE
- Sweden
- Prior art keywords
- piperazinecarboxylic acid
- disorders
- img
- tinnitus
- epilepsy
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- RFIOZSIHFNEKFF-UHFFFAOYSA-N piperazine-1-carboxylic acid Chemical compound OC(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-N 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
- 206010020852 Hypertonia Diseases 0.000 abstract 1
- 208000009205 Tinnitus Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 231100000886 tinnitus Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878703749A GB8703749D0 (en) | 1987-02-18 | 1987-02-18 | Piperazinecarboxylic acid |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8800541D0 SE8800541D0 (sv) | 1988-02-17 |
SE8800541A true SE8800541A (fr) | 1988-08-19 |
SE467256B SE467256B (sv) | 1992-06-22 |
Family
ID=10612501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8800541A SE467256B (sv) | 1987-02-18 | 1988-02-17 | /r-(e)/-4-(3-fosfono-2-propenyl)-2-piperazinkarboxylsyra, foerfarande foer framstaellning av denna och en farmaceutisk komposition innehaallande foereningen |
Country Status (28)
Country | Link |
---|---|
JP (1) | JPH0723387B2 (fr) |
KR (1) | KR960015190B1 (fr) |
AT (1) | AT391320B (fr) |
AU (1) | AU613009B2 (fr) |
BE (1) | BE1002427A3 (fr) |
CA (1) | CA1327799C (fr) |
CH (1) | CH675125A5 (fr) |
CY (1) | CY1739A (fr) |
DE (1) | DE3804936C2 (fr) |
DK (1) | DK168441B1 (fr) |
ES (2) | ES2011319A6 (fr) |
FI (1) | FI86733C (fr) |
FR (1) | FR2610932B1 (fr) |
GB (2) | GB8703749D0 (fr) |
GR (1) | GR1002471B (fr) |
HK (1) | HK142093A (fr) |
HU (2) | HU199858B (fr) |
IE (1) | IE59098B1 (fr) |
IL (1) | IL85436A0 (fr) |
IT (1) | IT1219447B (fr) |
LU (1) | LU87129A1 (fr) |
MY (1) | MY103206A (fr) |
NL (1) | NL8800412A (fr) |
NZ (1) | NZ223529A (fr) |
PH (1) | PH25512A (fr) |
PT (1) | PT86776B (fr) |
SE (1) | SE467256B (fr) |
ZA (1) | ZA881146B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU202111B (en) * | 1988-03-11 | 1991-02-28 | Sandoz Ag | Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component |
US5086072A (en) * | 1990-06-18 | 1992-02-04 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
EP0488959A3 (en) * | 1990-11-28 | 1992-08-05 | Sandoz Ltd. | New uses of competitive nmda receptor antagonists |
US5260286A (en) * | 1992-10-16 | 1993-11-09 | Japan Tobacco, Inc. | 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists |
JPH11508761A (ja) * | 1995-05-08 | 1999-08-03 | ロンザ アーゲー | R−α−ピペラジンカルボン酸およびS−α−ピペラジンカルボキサミドを製造する生物工学的方法 |
US6071915A (en) | 1997-05-12 | 2000-06-06 | Ortho-Mcneil Pharmaceutical, Inc. | Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia |
GB9821179D0 (en) * | 1998-09-30 | 1998-11-25 | Merck Sharp & Dohme | Therapeutic use |
JP2008124531A (ja) | 2006-11-08 | 2008-05-29 | Nec Electronics Corp | 半導体装置およびオーディオプロセッサチップ |
EP3427729A1 (fr) | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probénécide destiné à être utilisé dans le traitement de maladies, troubles ou états épileptiques |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1248531A (fr) * | 1984-04-17 | 1989-01-10 | Jeffrey C. Watkins | Derives de substitution en 4 d'acides piperazine-2- carboxyliques |
-
1987
- 1987-02-18 GB GB878703749A patent/GB8703749D0/en active Pending
-
1988
- 1988-02-11 LU LU87129A patent/LU87129A1/fr unknown
- 1988-02-12 IT IT47631/88A patent/IT1219447B/it active
- 1988-02-12 BE BE8800177A patent/BE1002427A3/fr active
- 1988-02-12 FR FR888801782A patent/FR2610932B1/fr not_active Expired - Lifetime
- 1988-02-15 MY MYPI88000155A patent/MY103206A/en unknown
- 1988-02-15 GB GB8803438A patent/GB2201676B/en not_active Expired - Lifetime
- 1988-02-16 CA CA000559170A patent/CA1327799C/fr not_active Expired - Fee Related
- 1988-02-16 AU AU11758/88A patent/AU613009B2/en not_active Ceased
- 1988-02-16 NZ NZ223529A patent/NZ223529A/xx unknown
- 1988-02-16 IL IL85436A patent/IL85436A0/xx not_active IP Right Cessation
- 1988-02-16 IE IE41388A patent/IE59098B1/en not_active IP Right Cessation
- 1988-02-16 CH CH549/88A patent/CH675125A5/de not_active IP Right Cessation
- 1988-02-16 HU HU88746A patent/HU199858B/hu not_active IP Right Cessation
- 1988-02-16 DK DK079688A patent/DK168441B1/da not_active IP Right Cessation
- 1988-02-16 PH PH36514A patent/PH25512A/en unknown
- 1988-02-16 GR GR880100084A patent/GR1002471B/el not_active IP Right Cessation
- 1988-02-17 KR KR1019880001680A patent/KR960015190B1/ko not_active IP Right Cessation
- 1988-02-17 FI FI880744A patent/FI86733C/fi not_active IP Right Cessation
- 1988-02-17 DE DE3804936A patent/DE3804936C2/de not_active Expired - Fee Related
- 1988-02-17 AT AT0036788A patent/AT391320B/de not_active IP Right Cessation
- 1988-02-17 JP JP63036458A patent/JPH0723387B2/ja not_active Expired - Lifetime
- 1988-02-17 SE SE8800541A patent/SE467256B/sv not_active IP Right Cessation
- 1988-02-17 PT PT86776A patent/PT86776B/pt not_active IP Right Cessation
- 1988-02-18 NL NL8800412A patent/NL8800412A/nl not_active Application Discontinuation
- 1988-02-18 ZA ZA881146A patent/ZA881146B/xx unknown
- 1988-02-18 ES ES888800466A patent/ES2011319A6/es not_active Expired - Lifetime
-
1989
- 1989-10-16 ES ES8903482A patent/ES2021904A6/es not_active Expired - Lifetime
-
1993
- 1993-12-30 HK HK1420/93A patent/HK142093A/xx not_active IP Right Cessation
-
1995
- 1995-06-09 HU HU95P/P00176P patent/HU211269A9/hu unknown
- 1995-10-20 CY CY173995A patent/CY1739A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69522947D1 (en) | Phenylxanthin-derivate | |
HU9300850D0 (en) | Sulphonamido-pyridine-2-carboxylic acid amides as well as sulphonamido-carbonyl- ones, their n-oxides, method for producing them and pharmaceutical preparatives containing them | |
IL83925A0 (en) | Compositions for treatment of skin disorders | |
IL143313A0 (en) | Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases | |
GB2207055B (en) | Apparatus for use in the treatment of spinal disorders | |
HUP0105027A2 (hu) | N-Heterociklusos vegyületek karbonsavszármazékai és karbonsav-izoszterei és alkalmazásuk | |
MY120976A (en) | 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines | |
SE8800541A (fr) | ||
GB9418912D0 (en) | Pharmaceutically active compounds | |
BE902040A (fr) | Alpha-aminoacides substitues, leur fabrication et compositions pharmaceutiques les contenant. | |
AU642428B2 (en) | Method of treatment of CNS disorders and /or pain using gamma aminobutyric acid autoreceptor antagonists | |
IE880704L (en) | Substituted benzamides. | |
IL126235A (en) | Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use | |
EP0383171A3 (fr) | Dérivés de 2,3,23 trihydroxy-urs-12-ène pour le traitement des troubles cognitifs | |
DK317285A (da) | Farmakologisk virksomme (pyrrol-1-yl)-phenyl-dihydropyridazinoner ogfremgangsmaade til fremstilling heraf | |
EP0273310A3 (fr) | 5-Aryl-3H-1,2,4-triazol-3-ones et leur emploi comme anticonvulsifs | |
MY105555A (en) | Heterocyclicguanidines as 5ht 3 antagonists. | |
BG104368A (en) | Novel polymorphic forms of cipamfylline | |
GB2204488B (en) | Pharmaceutical compositions for the treatment or prophylaxis of skin disorders | |
ZA883144B (en) | Novel substituted silyl alkylene amines | |
FR2612774B1 (fr) | Compositions cosmetiques et pharmaceutiques, utilisees pour traiter le processus de l'alopecie androgenogenetique, contenant de l'acide azelaique | |
MY103584A (en) | 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
GB8715914D0 (en) | Treatment of cerabral disorders | |
IL124729A (en) | Use of bismuth for the manufacture of compositions for the treatment and prevention of gastrointestinal disorders | |
ATE203671T1 (de) | Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8800541-8 Format of ref document f/p: F |
|
NUG | Patent has lapsed |